Methods, pharmaceutical compositions and kits for use in the treatment of adult T-cell leukemia/lymphoma
US9107893B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2014 |
| Grant date | Aug 18, 2015 |
| Priority date | — |
| Expiry date | Jun 11, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods, pharmaceutical compositions and kits for use in the treatment of Adult T-cell leukemia/lymphoma. More particularly, the present invention relates to a combination of an interferon, an arsenic compound and a reverse transcriptase inhibitor for the treatment of Adult T-cell leukemia/lymphoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.